Medtronic (MDT) PT Bumped to $91 at Needham & Company Post Q4

June 2, 2015 1:08 PM

Needham & Company analyst Mike Matson reiterated a Buy rating and bumped his price target on Medtronic, Inc. (NYSE: MDT) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found